Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #218345 on Biotech Values
Titan V
04/06/18 12:58 PM
#218349 RE: poorgradstudent #218345
The failed skin cancer trial that crushed Incyte and Merck on Friday could be cause for alarm over at Bristol-Myers Squibb, which is running a nearly identical study with two drugs of its own that work the same way. ... (paywall)